2025
SJR Q2
JCR Q2 · 2,9
17 eşleşen makale
SCIE
Dergi ayrıntısı
Microbes and Infection
- Yayıncı
- Elsevier Masson s.r.l.
- Ülke
- France · Western Europe
- Tür
- journal
- ISSN
-
128645791769714X
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,874
- Quartile Q2
- H-Index 165
- Atıf/yayın 3,11
- Doküman (3y) 300
- Atıf (3y) 965
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,9
- 5Y JIF 2,9
- JCI 0,79
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Immunology Q2
- Infectious Diseases Q2
- Microbiology Q2
Alanlar
- Immunology and Microbiology
- Medicine
WoS kategorileri
- Immunology | Infectious Diseases | Microbiology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,874 | 2,9 | 2,9 | 0,79 | Q2 | 165 |
| 2024 | Q2 | Q2 | 0,744 | 2,7 | 2,8 | 0,7 | Q2 | 160 |
| 2023 | Q2 | Q3 | 0,832 | 2,6 | 3 | 1,09 | Q1 | 160 |
| 2022 | Q2 | Q1 | 1,059 | 5,8 | 3,7 | 1,18 | Q1 | 160 |
| 2021 | Q1 | Q1 | 1,586 | 9,6 | 5,6 | 1,41 | Q1 | 160 |
| 2020 | Q2 | Q3 | 0,996 | 2,7 | 3,1 | 0,64 | Q3 | 160 |
| 2019 | Q2 | Q3 | 1,015 | 2,4 | 2,4 | 0,69 | Q3 | 160 |
| 2018 | — | Q3 | — | 2,7 | 2,4 | 0,73 | Q2 | — |
| 2017 | Q2 | Q2 | 1,205 | 2,9 | 2,5 | 0,69 | Q3 | 160 |
| 2016 | Q2 | Q3 | 1,102 | 2,2 | 2,5 | — | — | 160 |
| 2015 | Q1 | Q3 | 1,407 | 2,3 | 2,6 | — | — | 160 |
| 2014 | Q1 | Q2 | 1,584 | 2,9 | 2,9 | — | — | 160 |
| 2013 | Q1 | Q2 | 1,531 | 2,7 | 2,8 | — | — | 160 |
| 2012 | Q1 | Q2 | 1,467 | 2,9 | 2,8 | — | — | 160 |
| 2011 | Q1 | Q2 | 1,359 | 3,1 | 3 | — | — | 160 |
| 2010 | Q1 | Q2 | 1,516 | 2,7 | 2,9 | — | — | 160 |
| 2009 | — | Q2 | — | 2,8 | 3 | — | — | — |
| 2008 | — | Q2 | — | 2,8 | 3 | — | — | — |
| 2007 | — | Q2 | — | 2,5 | 3,2 | — | — | — |
| 2006 | — | Q2 | — | 3,1 | — | — | — | — |
| 2005 | — | Q2 | — | 3,2 | — | — | — | — |
| 2004 | — | Q1 | — | 3,8 | — | — | — | — |
| 2003 | — | Q1 | — | 3,8 | — | — | — | — |
| 2002 | — | Q1 | — | 3 | — | — | — | — |
| 2001 | — | Q2 | — | 2 | — | — | — | — |
| 2000 | — | Q3 | — | 1,1 | — | — | — | — |
| 1999 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q2 | 116/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 64/141 |
| 2025 | MICROBIOLOGY | SCIE | Q3 | Q2 | 101/167 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q2 | 112/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 61/137 |
| 2024 | MICROBIOLOGY | SCIE | Q3 | Q2 | 90/163 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q1 | 127/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q3 | Q1 | 69/132 |
| 2023 | MICROBIOLOGY | SCIE | Q3 | Q1 | 92/161 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q1 | 51/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 22/96 |
| 2022 | MICROBIOLOGY | SCIE | Q1 | Q1 | 27/135 |
| 2021 | IMMUNOLOGY | SCIE | Q1 | Q1 | 31/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q1 | Q1 | 16/95 |
| 2021 | MICROBIOLOGY | SCIE | Q1 | Q1 | 18/137 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q3 | 126/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 65/93 |
| 2020 | MICROBIOLOGY | SCIE | Q3 | Q3 | 96/136 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 117/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q3 | Q3 | 59/92 |
| 2019 | MICROBIOLOGY | SCIE | Q3 | Q3 | 89/136 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q2 | 102/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 45/89 |
| 2018 | MICROBIOLOGY | SCIE | Q3 | Q2 | 75/133 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q3 | 85/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q2 | Q3 | 36/88 |
| 2017 | MICROBIOLOGY | SCIE | Q2 | Q3 | 50/126 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 113/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q3 | — | 57/84 |
| 2016 | MICROBIOLOGY | SCIE | Q3 | — | 74/125 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 102/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q3 | — | 46/83 |
| 2015 | MICROBIOLOGY | SCIE | Q3 | — | 70/123 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 70/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q2 | — | 31/78 |
| 2014 | MICROBIOLOGY | SCIE | Q2 | — | 44/119 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 73/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q2 | — | 33/72 |
| 2013 | MICROBIOLOGY | SCIE | Q2 | — | 49/119 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 67/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q2 | — | 26/70 |
| 2012 | MICROBIOLOGY | SCIE | Q2 | — | 44/116 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 62/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q2 | — | 26/70 |
| 2011 | MICROBIOLOGY | SCIE | Q2 | — | 41/114 |
| 2010 | IMMUNOLOGY | SCIE | Q3 | — | 70/134 |
| 2010 | MICROBIOLOGY | SCIE | Q2 | — | 42/107 |
| 2010 | VIROLOGY | SCIE | Q2 | — | 16/33 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 64/128 |
| 2009 | MICROBIOLOGY | SCIE | Q2 | — | 40/95 |
| 2009 | VIROLOGY | SCIE | Q2 | — | 14/30 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 58/121 |
| 2008 | MICROBIOLOGY | SCIE | Q2 | — | 32/91 |
| 2008 | VIROLOGY | SCIE | Q2 | — | 13/27 |
| 2007 | IMMUNOLOGY | SCIE | Q3 | — | 61/119 |
| 2007 | MICROBIOLOGY | SCIE | Q2 | — | 35/93 |
| 2007 | VIROLOGY | SCIE | Q3 | — | 16/25 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 44/117 |
| 2006 | MICROBIOLOGY | SCIE | Q2 | — | 27/89 |
| 2006 | VIROLOGY | SCIE | Q2 | — | 9/23 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 38/115 |
| 2005 | MICROBIOLOGY | SCIE | Q2 | — | 22/86 |
| 2005 | VIROLOGY | SCIE | Q2 | — | 8/23 |
| 2004 | IMMUNOLOGY | SCIE | Q1 | — | 21/111 |
| 2004 | MICROBIOLOGY | SCIE | Q1 | — | 18/84 |
| 2004 | VIROLOGY | SCIE | Q1 | — | 5/22 |
| 2003 | IMMUNOLOGY | SCIE | Q1 | — | 22/114 |
| 2003 | MICROBIOLOGY | SCIE | Q1 | — | 14/84 |
| 2003 | VIROLOGY | SCIE | Q1 | — | 5/23 |
| 2002 | IMMUNOLOGY | SCIE | Q2 | — | 31/119 |
| 2002 | MICROBIOLOGY | SCIE | Q1 | — | 18/82 |
| 2002 | VIROLOGY | SCIE | Q2 | — | 7/24 |
| 2001 | IMMUNOLOGY | SCIE | Q3 | — | 61/114 |
| 2001 | MICROBIOLOGY | SCIE | Q2 | — | 34/81 |
| 2001 | VIROLOGY | SCIE | Q3 | — | 13/25 |
| 2000 | IMMUNOLOGY | SCIE | Q3 | — | 86/116 |
| 2000 | MICROBIOLOGY | SCIE | Q3 | — | 53/83 |
| 2000 | VIROLOGY | SCIE | Q3 | — | 21/28 |
| 1999 | IMMUNOLOGY | SCIE | — | — | — |
| 1999 | MICROBIOLOGY | SCIE | — | — | — |
| 1999 | VIROLOGY | SCIE | — | — | — |